Ischemic stroke is caused by a disruption in blood supply to a region of the brain. It induces
dysfunction of brain cells and networks, resulting in sudden neurological deficits. The cause …

The occurrence of the no-reflow phenomenon still represents an important clinical issue
during pPCI and can negate the benefits of restoring culprit-vessel patency. Novel promising …

Objectives We aimed to compare intracoronary (IC) epinephrine versus conventional
treatments alone in patients with ST‐elevation myocardial infarction and refractory coronary …

Myocardial infarction (MI) eventually exacerbates inflammatory response due to the release
of inflammatory and pro-inflammatory factors. The aim of this study is to explore the …

Currently, there is still a lack of an optimal treatment for no reflow phenomenon (NRP). We
analyzed the efficacy and safety of using nondihydropyridine calcium channel antagonists …

Background This study aimed to investigate intracoronary nicorandil treatment on the no-
reflow phenomenon (NRP) during primary percutaneous coronary intervention (PCI) in …

Background and Purpose—Proper brain function is maintained by an integrated system
called the neurovascular unit (NVU) comprised cellular and acellular elements. Although the …

Cardiovascular events are one of the leading causes of death in the world. Thrombolysis,
percutaneous transluminal coronary angioplasty, and coronary bypass surgery are the …

Background: Nicorandil prior to reperfusion by primary percutaneous coronary intervention
(PCI) in patients with ST-segment elevated myocardial infarction (STEMI) has been …

OBJECTIVE: Numerous mechanisms have been proposed for the no-reflow phenomenon
(NRP) in the literature including leukocyte intravascular plugging, microembolisms, and …